Advertisement

Organisation › Details
Tempus (Group)
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. *
![]() |
Start | 2015-01-01 established |
![]() |
Industry | personalised medicine / precision medicine |
Industry 2 | bioinformatics (biological software and databases) | |
![]() |
Person | Lefkofsky, Eric (Tempus Labs 202003 CEO + Founder) |
![]() |
Region | Chicago, IL |
Country | United States (USA) | |
City | n. a. Chicago, IL | |
Address record changed: 2024-09-04 | ||
Basic data | Employees | F: 1,001 to 5,000 (2020-12-10) |
* Document for »About Section«: Tempus AI, Inc.. (9/4/24). "Press Release: Tempus Announces Real World Data Collaboration with BioNTech". Chicago. | ||
Record changed: 2024-09-04 |
Advertisement

More documents for Tempus (Group)
- [1] Tempus AI, Inc.. (9/4/24). "Press Release: Tempus Announces Real World Data Collaboration with BioNTech". Chicago....
- [2] GSK plc. (10/18/22). "Press Release: GSK Announces Expanded Collaboration with Tempus in Precision Medicine to Accelerate R&D". London....
- [3] Tempus Labs, Inc.. (12/10/20). "Press Release: Tempus Announces $200 Million Series G-2 Financing"....
- [4] Tempus Labs, Inc.. (3/13/20). "Press Release: Tempus Announces $100 Million in Series G Financing"....
- [5] Genmab A/S. (9/9/19). "Press Release: Genmab and Tempus Enter into Strategic Collaboration Agreement". Copenhagen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top